Found: 31
Select item for more details and to access through your institution.
An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6997
- By:
- Publication type:
- Article
A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
- By:
- Publication type:
- Article
Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3471, doi. 10.3390/cancers15133471
- By:
- Publication type:
- Article
In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T‐cell inhibitory properties, contributing to immunosuppression.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 371, doi. 10.1111/ejh.13912
- By:
- Publication type:
- Article
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 149, doi. 10.1111/ejh.13884
- By:
- Publication type:
- Article
Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 45, doi. 10.1111/bjh.18479
- By:
- Publication type:
- Article
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 24, p. 8866, doi. 10.1002/cam4.4387
- By:
- Publication type:
- Article
Attenuated humoral immune response following anti‐SARS‐CoV‐2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E475, doi. 10.1002/ajh.26373
- By:
- Publication type:
- Article
Continuous Remote Patient Monitoring Shows Early Cardiovascular Changes in COVID-19 Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4218, doi. 10.3390/jcm10184218
- By:
- Publication type:
- Article
Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01501-9
- By:
- Publication type:
- Article
ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S395, doi. 10.1016/S2152-2650(21)01896-6
- By:
- Publication type:
- Article
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 17, doi. 10.1111/bjh.16893
- By:
- Publication type:
- Article
Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10<sup>+</sup> diffuse large B‐cell lymphoma and follicular lymphoma.
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 5, p. 449, doi. 10.1002/cyto.b.21861
- By:
- Publication type:
- Article
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E3, doi. 10.1002/ajh.25651
- By:
- Publication type:
- Article
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcomes of Post-Induction Bortezomib Therapy in Patients with Newly diagnosed Multiple Myeloma: A Multi-Center Retrospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e296, doi. 10.1016/j.clml.2019.09.486
- By:
- Publication type:
- Article
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 992, doi. 10.1002/ajh.25558
- By:
- Publication type:
- Article
577-P: Increased Symptoms of Peripheral Neuropathy and Depression in Insulin-Treated Type 2 Diabetic Patients Are Associated with Reduced BDNF Serum Protein Levels and Val66Met-SNP.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-577-P
- By:
- Publication type:
- Article
Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine‐induced peripheral neuropathy in patients with lymphoma.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 175, doi. 10.1111/bjh.15428
- By:
- Publication type:
- Article
Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine‐induced peripheral neuropathy in patients with lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 175, doi. 10.1111/bjh.15428
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 739, doi. 10.1007/s00262-018-2128-x
- By:
- Publication type:
- Article
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 709, doi. 10.1111/bjh.14734
- By:
- Publication type:
- Article
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3+7" induction regimen for acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 12, p. 1159, doi. 10.1002/ajh.24207
- By:
- Publication type:
- Article
A 14-Year Experience in the Management of Patients with Acquired Immune Thrombotic Thrombocytopenic Purpura in Northern Israel.
- Published in:
- Acta Haematologica, 2015, v. 134, n. 3, p. 170, doi. 10.1159/000371867
- By:
- Publication type:
- Article
Author response: Precise staging of lymphoma duringpregnancy using MRI is not always crucial.
- Published in:
- Women's Health (17455057), 2015, v. 11, n. 2, p. 103, doi. 10.2217/whe.14.76
- By:
- Publication type:
- Article
Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy.
- Published in:
- Rambam Maimonides Medical Journal, 2014, v. 5, n. 4, p. 1, doi. 10.5041/RMMJ.10172
- By:
- Publication type:
- Article
An update on the management of hematologic malignancies in pregnancy.
- Published in:
- Women's Health (17455057), 2014, v. 10, n. 3, p. 255, doi. 10.2217/WHE.14.17
- By:
- Publication type:
- Article
Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 3, p. 454, doi. 10.1111/bjh.12624
- By:
- Publication type:
- Article
New Rising Infection: Human Herpesvirus 6 Is Frequent in Myeloma Patients Undergoing Autologous Stem Cell Transplantation after Induction Therapy with Bortezomib.
- Published in:
- Bone Marrow Research, 2012, p. 1, doi. 10.1155/2012/409765
- By:
- Publication type:
- Article